Correlates of Nonmedical Use of Hydromorphone and Hydrocodone

REFERENCES

• Butler S F, Benoit C, Budman S H, Fernandez K C, McCormick C, Venutli S W, Katz N. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduction J 2006; 3(5)1–11
   PubMedGoogle Scholar
• Epstein D H, Preston K L, Jasinski D R. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: Lessons from tramadol. Biol Psychol 2006; 73: 90–99
   PubMed Web of Science ®Google Scholar
• Gilson A M, Ryan K M, Joranson D E, Dahl J L. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain SymptomManage 2004; 28: 176–188
   PubMed Web of Science ®Google Scholar
• Zacny J P, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Dep 2003; 69: 215–232
   PubMed Web of Science ®Google Scholar
• Zacny J P, Gutierrez S, Bolbolan S A. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users. Drug Alcohol Dep 2005; 78: 243–252
   PubMed Web of Science ®Google Scholar
• Compton W M, Volkow N D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Dep 2006; 81: 103–107
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Office of Applied Studies. Rockville, MDUSA 2005; 232–233; 262, Results from the 2004 National Survey on Drug Use and Health: National Findings. NSDUH Series H-28, DHHS Publication No. (SMA) 05–4062
   Google Scholar
• Johnston L D, O'Malley P M, Bachman J G, Schulenberg J E. Monitoring the Future national survey results on drug use, 1975–2004. National Institute on Drug Abuse, Bethesda, MD 2005; Volume I: 680, Secondary school students (NJH Publication No. 05–5727)
   Google Scholar
• Johnston L D, O'Malley P M, Bachman J G, Schulenberg J E. Monitoring the Future national survey results on drug use, 1975–2004. National Institute on Drug Abuse, Bethesda, MD 2005; Volume II: 278, College students and adults ages 19–45 (NIH Publication No. 05–5728)
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2003: Interim National Estimates of Drug-Related Emergency Department Visits. DHHS, Rockville, MDUSA 2004, DAWN Series D-26 Publication No.(SMA) 04–3972
   Google Scholar
• Boyd C J, McCabe S E, Teter C J. Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district. Drug Alcohol Dep 2006; 81: 37–45
   PubMed Web of Science ®Google Scholar
• Cottier L B, Robins L N. The prevalence and characteristics of psychoactive medication use in a general population study. Psychopharmacol Bull 1983; 19: 746–753
   Google Scholar
• Simoni-Wastila L J. Gender and psychotropic drug use. MedCare 1998; 36: 88–94
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L J. The use of abusable prescription drugs: the role of gender. J Women's Health & Gender-Based Med 2000; 9: 289–297
   Web of Science ®Google Scholar
• Simon-Wastila L, Strickler G. Risk factors associated with problem use of prescription drugs. Am J Public Health 2004; 94: 266–268
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L J, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004; 39: 1–23
   PubMed Web of Science ®Google Scholar
• Wells K B, Kamberg C, Brook R, Camp P, Rogers W. Health status, sociodemographic factors, and the use of prescribed psychotropic drugs. Med Care 1985; 23: 1295–1301
   PubMed Web of Science ®Google Scholar
• Brooner R K, King V L, Kidorf M, Schmidt C W, Bigelow G E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psych 1997; 54: 71–80
   PubMed Web of Science ®Google Scholar
• Hays L R. A profile of OxyContin addiction. J Addict Dis 2004; 23: 1–9
   PubMed Web of Science ®Google Scholar
• Hays L, Kirsh K L, Passik S D. Seeking drug treatment for OxyContin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in Kentucky. J Natl Compr Cane Netw 2003; 1: 423–428
   PubMedGoogle Scholar
• Katz D A, Hays L R. Adolescent OxyContin abuse. J Am Acad Child Adolesc Psychiatry 2004; 43: 231–234
   PubMed Web of Science ®Google Scholar
• Lane J, Gerstein D, Huang L, Wright D. Risk and protective factors for adolescent drug use: Findings from the 1997 National Household Survey on Drug Abuse. Substance Abuse and Mental Health Services Administration, Rockville, MD 2001, DHHS Publication No. SMA 01–3499, Analytic Series A-12
   Google Scholar
• Lawrence D A. How I keep from being conned by drug abusers. Virginia Med 1978; 780–783, November
   Google Scholar
• Levine D G, Preston P A, Lipscomb S G. A historical approach to understanding drug abuse among nurses. AmJ Psychiatry 1974; 131: 1036–1037
   PubMed Web of Science ®Google Scholar
• Lieb R, Pfister H, Wittchen H. Use, abuse and dependence of prescription drugs in adolescents and young adults. Eur Addict Res 1998; 4: 67–74
   PubMed Web of Science ®Google Scholar
• Lindberg D K. How the addict gets his prescription. J Florida Med Assoc 1984; 71: 240–243
   PubMedGoogle Scholar
• Manchikanti L, Manchukonda R, Pampati V, Damron K S. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician 2005; 8: 257–261
   PubMedGoogle Scholar
• McBride D C, McCoy C B, Rivers J E, Lincoln C A. Dilaudid® use: Trends and characteristics of users. Chem Dependencies: Behav and Biomed Issues 1980; 4: 85–100
   PubMedGoogle Scholar
• Miller M S, Greenfeld A. Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone. Am J Ther 2004; 11: 26–32
   PubMedGoogle Scholar
• Passik S D, Hays L, Eisner N, Kirsh K L. Psychiatric and Pain Characteristics of Prescription Drug Abusers Entering Drug Rehabilitation. J Pain Palliât Care Pharmacother 2006; 20: 5–13
   PubMedGoogle Scholar
• Pollock R WQ, Campbell N A, Hachadorian C. An analysis of controlled substances rx forgeries in Rhode Island. Rhode Island Med J 1977; 386–410, August
   PubMedGoogle Scholar
• Potter J S, Hennessy G, Borrow J A, Greenfield S F, Weiss R D. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Dep 2004; 76: 213–215
   PubMed Web of Science ®Google Scholar
• Sees K L, DiMarino M E, Ruediger N K, Sweeney C T, Shiffman S. Non-Medical use of OxyContin tablets in the United States. J Pain Palliât Care Pharmacother 2005; 19: 13–23
   PubMedGoogle Scholar
• Buchanan D, Tooze J A, Shaw S, Kinzly M, Heimer R, Singer M. Demographic, HIV risk behavior and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities. Drug Alcohol Dep 2006; 81: 221–229
   PubMed Web of Science ®Google Scholar
• Golub A, Johnson B D. The crack epidemic: Empirical findings support an hypothesized diffusion of innovation process. Socio-Econ Plann Sci 1996; 30: 221–231
   Web of Science ®Google Scholar
• Jacox A, Carr D B, Payne R, et al. Management of Cancer Pain. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, Rockville, MD March, 1994; 49–65, Clinical Practice Guideline No. 9. AHCPR Publication No. 94–0592
   Google Scholar
• Newcomb M D, Maddahian E, Bentler P M. Risk factors for drug use among adolescents: Concurrent and longitudinal analysis. Am J Public Health 1986; 76: 525–531
   PubMed Web of Science ®Google Scholar
• Petraitis J, Flay B R, Miller T Q, Torpy E J, Greiner B. Illicit substance use among adolescents: A matrix of prospective predictors. Subst Use and Misuse 1998; 33: 2561–2604
   PubMed Web of Science ®Google Scholar
• Everson A, Segal R. Trends in narcotic use in Toronto and treatment response. Canadian J Pub Health 1976; 6: 489–494
   Google Scholar
• Garriot J C, Baselt R C. Deaths involving hydromorphone (Dilaudid®). The Forensic Science Gazette from the Southwestern Institute of Forensic Sciences, Dallas, Texas 1978; 9, July-September
   Google Scholar
• Morbidity and Mortality Weekly Report: Epidemiologic notes and reports Dilaudid®-related deaths-District of Columbia, 1987. MMWR 1988; 37: 425–427
   PubMedGoogle Scholar
• Drummer O H. Recent trends in narcotic deaths. Ther Drug Monit 2005; 27: 738–740
   PubMed Web of Science ®Google Scholar
• Physicians' Desk Reference 59th Edition. Thomson PDR, Des Moines 2005
   Google Scholar
• Pharmacy Facts and Figures: Top 200 generic drugs by units in 2005. Drug Topics: The online newsmagazine for pharmacists, http://www.drugtopics.com/drugtopics/article/articleList.jsp?categoryId=7604. Accessed August 16, 2006.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Office of Applied Studies. Results from the 2003 National Survey on Drug Use and Health: National Findings. DHHS, Rockville, MDUSA 2004, NSDUH Series H-25 Publication No. SMA 04–3964
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• RTI International. SUDAAN User's Manual: release 9.01. RTI International, Research Triangle Park 2001
   Google Scholar
• IMS HEALTH. National Prescription Audit, in Retail Pharmacies, Long-Term Care and Mail Order
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Rockville, MD 2006, (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06–4194)
   Google Scholar
• Jessor R, Donovan J E, Costa F. Beyond adolescence: Problem behavior and young adult development. Cambridge University Press, CambridgeUK 1991
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Office of Applied Studies, Results from the 2002 National Survey on Drug Use and Health: National Findings. Rockville, MD 2003, NHSDA Series H-22, DHHS Publication No. SMA 03–3836. Available at: http://www.oas.samhsa.gov/nhsda/2k2nsduh/Results/appB.htm
   Google Scholar
• Golub A, Johnson B D. The shifting importance of alcohol and marijuana as gateway substances among serious drug users. J Alcohol Stud 1994; 55: 607–614
   PubMed Web of Science ®Google Scholar
• Kandel D B. Convergence in prospective longitudinal surveys of drug use in normal populations. Longitudinal research on drug use: Empirical findings and methodological issues, D B Kandel. Hemisphere Publishing, Washington, DC 1978; 3–38
   Google Scholar
• Kandel D B, Logan J A. Patterns of drug use from adolescence to adolescence to young adulthood: I. Periods of risk for initiation, continued use, and discontinua-tion. Am J Public Health 1984; 74: 660–666
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Kandel D B. Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. Am J Public Health 1984; 74: 673–681
   PubMed Web of Science ®Google Scholar